Dr. Lynch most recently served as chief scientific officer at New York City-based pharmaceutical manufacturer Bristol-Myers Squibb.
While at Bristol-Myers Squibb, he focused on cancer, cardiovascular disease, fibrosis and immunoscience research and development efforts, including translational immuno-oncology research, according to a news release.
Dr. Lynch’s previous positions include chairman and CEO of Massachusetts General Physicians Organization, a multispecialty medical group; director of Yale Cancer Center; physician-in-chief of Yale’s Smilow Cancer Hospital in New Haven, Conn.; professor of medicine at Yale School of Medicine; chief of hematology-oncology at Boston-based Massachusetts General Hospital; and professor of medicine at Harvard Medical School.
More articles on executive moves:
AdventHealth taps Justin Birmele to helm Winter Park hospital
Cape Fear Valley Health System CEO Mike Nagowski returns from medical leave
Joseph Mullany named president of Vassar Brothers Medical Center
